期刊文献+

^(18)F-FDG PET/CT对Ia期肺癌患者复发预测的初步研究 被引量:1

Preliminary Study of Predicting Recurrence of Stage Ia Lung Cancer with ^(18)F-FDG PET/CT
下载PDF
导出
摘要 目的:探讨18F-FDG PET/CT显像对Ia期肺癌患者复发预测的价值。方法:收集2005年1月至2009年4月在本PET/CT中心检查的肺孤立性结节患者259例,经手术证实为Ia期肺癌患者70例,失访28例,42例纳入研究。随访2年以上明确复发者13例,无复发者29例。将性别、年龄、病灶大小、平均SUV值、最大SUV值及病理类型纳入研究变量行单因素生存分析及Cox比例风险模型多因素分析。结果:单因素分析显示:最大SUV<5.0组及>5.0组的平均复发时间分别为66.98m、45.29m(P=0.01),年龄、性别、病灶大小、平均SUV不同分组的平均复发时间差别无统计学差异(P<0.05)。多因素分析显示:最大SUV值是影响Ia期肺癌复发的重要因素(P=0.02),最大SUV值每升高"1",患者复发风险升高15.5%。结论:18F-FDG PET/CT所提供的病灶最大SUV值对Ia期肺癌患者复发具有一定的预测价值。 Purpose: To study the prognostic value of 18F-FDG PET/CT in patients with completely resected stage IA lung caner. Methods: Two hundreds and fifty-nine patients with solitary pulmonary nodule from Jan 2005 to Apr 2009 were collected in our PET/CT center. Among these patients, 70 patients were diagnosed as stage Ia lung cancer according to the post-surgical pathology. Of these 70 patients, 42 were included in our study and 28 patients were excluded because of losing follow-up. Thirteen patients had tumor recurrence and 29 patients had no recurrence according to more than 2 years' follow-up. Six prognostic factors including age, sex, lesion size, average SUV, maximal SUV and pathological type were selected as the research variables. Kaplan-Meier survival analysis method was used for the univariate analysis. Differences in observed survival between groups were tested for significance using the log rank test. Cox regression method was used for the multivariate analysis. Results: The univariate analysis identified that the average time of recurrence was 66.98m for the patients with maximal SUV〉5.0 and 45.29m for the patients with maximal SUV〈5.0 (P=0.01). Other factors including age, sex, lesion size and average SUV were not related to the prognosis of stage Ia lung cancer (P〈0.05). Cox regression analysis showed that maximal SUV was important prognostic factor for predicting recurrence (P=0.02). A oneunit increase of maximal SUV corresponded with a 15.5% increase of risk of recurrence. Conclusion: The maximal SUV from 18F-FDG PET/CT was related with the time of recurrence and had high clinical value for predicting the recurrence of stage Ia lung cancer.
出处 《中国医学计算机成像杂志》 CSCD 北大核心 2013年第6期545-548,共4页 Chinese Computed Medical Imaging
基金 上海交通大学医学院附属仁济医院科研培育基金项目(编号:RJPY10-006) 上海市卫生局青年科研项目(编号:20114Y182)~~
关键词 肺肿瘤 预后 体层摄影术 发射型计算机 标准化摄取值 Lung neoplasms Prognosis Tomography, emission-computed Standardized uptake value
  • 相关文献

参考文献12

  • 1Higashi K, Ueda Y, Arisaka Y, et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.J Nucl Med. 2002, 43: 39-45.
  • 2Eschmann SM, Friedel G, Paulsen F, et al. Is standardised[18F] F - FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? EurJ Nucl Med Mol Imaging, 2006, 33: 389.
  • 3Sasaki R, Komaki R, Macapinlac H, et al.[18F] fluorodeoxyglucoseuptake by positron emission tomography predicts outcome of non-small-cell lung cancerJ Clin Oncol, 2005, 23: 1136-1143.
  • 4陈香,赵军,管一晖,陆舜,左传涛,华逢春.^(18)F-FDG PET显像在肺癌预后评价中的应用[J].中华核医学杂志,2007,27(5):269-272. 被引量:11
  • 5Vesselle H, Salskov A, Turcotte E, et al. Relationship between non?small cell lung cancer FDG uptake at PET, tumor histology, and Ki- 67 proliferation index.J Thorac Oncol, 2008, 3: 971-978.
  • 6Takenaka T, Yano T, Ito K, et al. Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer.J Surg Oncol, 2009, 15: 100: 688-692.
  • 7Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fiuorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC) : a systematic review and meta?analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.J Thorac Oncol, 2008, 3: 6-12.
  • 8Cerfolio RJ, Bryant AS, Ohja B, et al. The maximum standardized uptake values on positron emission tomography for a non-small cell lung cancer predict stage, recurrence, and survival.J Thorac Cardiovasc Surg, 2005, l30: l31-159.
  • 9Detterbeck FC, Boffa OJ, Tanoue LT. The new lung cancer staging system. Chest, 2009, 136: 260-271.
  • 10Alam N, Darling G, Evans WK, et al. Adjuvant chemotherapy for completely resected non-small cell lung cancer: a systematic review. Crit Rev Oncol Hematol, 2006,58: 146-155.

二级参考文献15

  • 1黄国俊,张德超,毛友生,李鉴,王永岗,王大力,薛奇,高树庚,张良泽,雷文东,高禹舜,赵峻,黄进丰,杨昆,苏凯,朱守营,韦森,冯飞跃.肺癌的临床分期与外科病理TNM分期比较[J].中华肿瘤杂志,2005,27(9):551-553. 被引量:22
  • 2Ahuja V, Coleman RE, Herndon J, et al. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer, 1998, 83 : 918-924.
  • 3Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Prognostic importance of the standardized uptake value on ^18F-fluoro-2-deoxyglucose-positron emission tomography scan in non-small cell lung cancer: an analysis of 125 cases. J Clin Oncol, 1999, 17: 3201- 3206.
  • 4Dhital K, Saunders CA, Seed PT, et al. ^18F-Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorae Surg, 2000, 18: 425-428.
  • 5Hicks RJ, Kalff V, MacManus MP, et al. ^18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med, 2001, 42: 1596-1604.
  • 6Higashi K, Ueda Y, Arisaka Y, et al. ^18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med, 2002, 43: 39-45.
  • 7Jeong HJ, Min JJ, Park JM, et al. Determination of the prognostic value of ^18F-fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun, 2002, 23: 865-870.
  • 8Downey R J, Akhurst T, Gonen M, et al. Preoperative ^18F-fluoro- deoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol, 2004, 22: 3255-3260.
  • 9Borst GR, Belderbos JS, Boellaard R, et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer, 2005,41 : 1533-1541.
  • 10Cerfolio R J, Bryant AS, Ohja B, et al. The maximum standardised uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg, 2005, 130: 151-159.

共引文献10

同被引文献26

  • 1陈香,赵军,管一晖,陆舜,左传涛,华逢春.^(18)F-FDG PET显像在肺癌预后评价中的应用[J].中华核医学杂志,2007,27(5):269-272. 被引量:11
  • 2SiegelR, MaJ, ZouZ, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1):9-29. DOI:10.3322/caac.21208.
  • 3HattoriA, SuzukiK, MatsunagaT, et al. Is limited resection appropriate for radiologically"solid"tumors in small lung cancers?[J]. Ann Thorac Surg, 2012, 94(1):212-215. DOI:10.1016/j.athoracsur.2012.03.033.
  • 4GoldstrawP, CrowleyJ, ChanskyK, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours[J]. J Thorac Oncol, 2007, 2(8):706-714.DOI:10.1097/JTO.0b013e31812f3c1a.
  • 5KenfieldSA, WeiEK, StampferMJ, et al. Comparison of aspects of smoking among the four histological types of lung cancer[J]. Tob Control, 2008, 17(3):198-204.DOI:0.1136/tc.2007.022582.
  • 6SicaG, YoshizawaA, SimaCS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors[J]. Am J Surg Pathol, 2010, 34(8):1155-1162. DOI:10.1097/PAS.0b013e3181e4ee32.
  • 7NakayamaH, OkumuraS, DaisakiH, et al. Value of integrated positron emission tomography revised using a phantom study to evaluate malignancy grade of lung adenocarcinoma: a multicenter study[J]. Cancer, 2010, 116(13):3170-3177. DOI:10.1002/cncr.25244.
  • 8SuzawaN, ItoM, QiaoS, et al. Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size[J]. Lung Cancer, 2011, 72(2):191-198. DOI:10.1016/j.lungcan.2010.08.017.
  • 9de Geus-OeiLF, van KriekenJH, AliredjoRP, et al. Biological correlates of FDG uptake in non-small cell lung cancer[J]. Lung Cancer, 2007, 55(1):79-87. DOI:10.1016/j.lungcan.2006.08.018.
  • 10HaraT, KosakaN, SuzukiT, et al. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study[J]. Chest, 2003, 124(3):893-901. DOI:10.1378/chest.124.3.893.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部